Gemlapodect is a phosphodiesterase 10A (PDE10A) inhibitor currently undergoing clinical trials for use as a treatment for Tourette's Syndrome by modulating the signaling of D2 receptors. PDE10A is highly expressed in striatal medium spiny neurons, with inhibition leading to behavioral and antipsychotic effects.
MedKoo Cat#: 130030
Name: Gemlapodect
CAS#: 1380329-87-2
Chemical Formula: C22H21N7O3
Exact Mass: 431.1706
Molecular Weight: 431.46
Elemental Analysis: C, 61.24; H, 4.91; N, 22.73; O, 11.12
The following data is based on the product molecular weight 431.46 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |